SCHEMBL7279745

SCHEMBL7279745

O=C(NC1CCN2CCCC1C2)c1cnc2ccsc2c1O

nearest known ligand 0.47

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
HTR3A P46098 5/20 0.47
HTR3E A5X5Y0 4/20 0.47
HTR3B O95264 4/20 0.47
HTR3D Q70Z44 4/20 0.47
HTR3C Q8WXA8 4/20 0.47
NPSR1 Q6W5P4 1/20 0.43
CYP3A4 P08684 1/20 0.43
CHRNA7 P36544 4/20 0.38
CHRNB4 P30926 1/20 0.37
CHRNA3 P32297 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Pumosetrag SCHEMBL1497800 0.88 HTR3A (0.56) HTR3AHTR3EHTR3BHTR3DHTR3C
Pumosetrag SCHEMBL1497797 0.88 HTR3A (0.56) HTR3AHTR3EHTR3BHTR3DHTR3C
Pumosetrag SCHEMBL7287985 0.88 HTR3A (0.56) HTR3AHTR3EHTR3BHTR3DHTR3C
Pumosetrag SCHEMBL9432501 0.87 HTR3A (0.55) HTR3AHTR3EHTR3BHTR3DHTR3C
Pumosetrag SCHEMBL9432490 0.87 HTR3A (0.55) HTR3AHTR3EHTR3BHTR3DHTR3C
SCHEMBL7334303 0.73 CYP3A4 (0.34) HTR3ACYP3A4
SCHEMBL7279446 0.73 HTR3E (0.46) HTR3AHTR3EHTR3BHTR3DHTR3C
SCHEMBL7284925 0.71 MEN1 (0.46) HTR3AHTR3EHTR3BHTR3DHTR3C
SCHEMBL7441918 0.69 HTR3E (0.53) HTR3AHTR3EHTR3BHTR3DHTR3C
SCHEMBL9059703 0.69 CHRNA7 (0.53) HTR3ACHRNA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0560348-B1 Thieno 3,2-b pyridine derivatives for the treatment of gastrointestinal disorders MITSUBISHI CHEM CORP (JP) 2002-07-10 EP disclosed
US-5352685-A Gastrointestinal disorders MITSUBISHI KASEI CORPORATION (JP) 1994-10-04 US disclosed
EP-0560348-A1 Thieno 3,2-b pyridine derivatives for the treatment of gastrointestinal disorders Mitsubishi Chemical Corporation (JP) 1993-09-15 EP disclosed